Free sialic acid storage disorder: Progress and promise.


Journal

Neuroscience letters
ISSN: 1872-7972
Titre abrégé: Neurosci Lett
Pays: Ireland
ID NLM: 7600130

Informations de publication

Date de publication:
11 06 2021
Historique:
received: 14 01 2021
revised: 06 04 2021
accepted: 08 04 2021
pubmed: 17 4 2021
medline: 15 12 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

Lysosomal free sialic acid storage disorder (FSASD) is an extremely rare, autosomal recessive, neurodegenerative, multisystemic disorder caused by defects in the lysosomal sialic acid membrane exporter SLC17A5 (sialin). SLC17A5 defects cause free sialic acid and some other acidic hexoses to accumulate in lysosomes, resulting in enlarged lysosomes in some cell types and 10-100-fold increased urinary excretion of free sialic acid. Clinical features of FSASD include coarse facial features, organomegaly, and progressive neurodegenerative symptoms with cognitive impairment, cerebellar ataxia and muscular hypotonia. Central hypomyelination with cerebellar atrophy and thinning of the corpus callosum are also prominent disease features. Around 200 FSASD cases are reported worldwide, with the clinical spectrum ranging from a severe infantile onset form, often lethal in early childhood, to a mild, less severe form with subjects living into adulthood, also called Salla disease. The pathobiology of FSASD remains poorly understood and FSASD is likely underdiagnosed. Known patients have experienced a diagnostic delay due to the rarity of the disorder, absence of routine urine sialic acid testing, and non-specific clinical symptoms, including developmental delay, ataxia and infantile hypomyelination. There is no approved therapy for FSASD. We initiated a multidisciplinary collaborative effort involving worldwide academic clinical and scientific FSASD experts, the National Institutes of Health (USA), and the FSASD patient advocacy group (Salla Treatment and Research [S.T.A.R.] Foundation) to overcome the scientific, clinical and financial challenges facing the development of new treatments for FSASD. We aim to collect data that incentivize industry to further develop, obtain approval for, and commercialize FSASD treatments. This review summarizes current aspects of FSASD diagnosis, prevalence, etiology, and disease models, as well as challenges on the path to therapeutic approaches for FSASD.

Identifiants

pubmed: 33862140
pii: S0304-3940(21)00274-3
doi: 10.1016/j.neulet.2021.135896
pmc: PMC8175077
mid: NIHMS1701408
pii:
doi:

Substances chimiques

Organic Anion Transporters 0
Symporters 0
sialic acid transport proteins 0
N-Acetylneuraminic Acid GZP2782OP0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

135896

Subventions

Organisme : NICHD NIH HHS
ID : P50 HD105352
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD045561
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD090260
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 HG000215
Pays : United States

Investigateurs

David R Adams (DR)
Kostantin Dobrenis (K)
Jessica Foglio (J)
William A Gahl (WA)
Bruno Gasnier (B)
Mary Hackbarth (M)
Marjan Huizing (M)
Monkol Lek (M)
May C V Malicdan (MCV)
Liisa E Paavola (LE)
Marc C Patterson (MC)
Richard Reimer (R)
Steven U Walkley (SU)
Melissa Wasserstein (M)
Raymond Y Wang (RY)
Roberto Zoncu (R)

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Références

Curr Pharm Des. 2019;25(17):1933-1950
pubmed: 31566121
Bone. 2017 Sep;102:50-59
pubmed: 28167345
J Biol Chem. 1959 Aug;234(8):1971-5
pubmed: 13672998
Glycobiology. 2012 Jul;22(7):880-96
pubmed: 22377912
Biochem J. 2013 Aug 15;454(1):31-8
pubmed: 23889254
J Am Soc Nephrol. 2016 Jun;27(6):1678-88
pubmed: 26449607
Clin Chim Acta. 1968 Jul;21(1):61-9
pubmed: 5658957
Science. 1908 Jul 10;28(706):49-50
pubmed: 17779291
J Inherit Metab Dis. 2001 Jun;24(3):328-36
pubmed: 11486897
Genomics. 1995 May 20;27(2):286-92
pubmed: 7557994
Adv Carbohydr Chem Biochem. 2010;64:403-79
pubmed: 20837202
Am J Hum Genet. 1995 Oct;57(4):893-901
pubmed: 7573051
J Inherit Metab Dis. 2021 Mar;44(2):301-311
pubmed: 33141457
EMBO Mol Med. 2016 Jan 19;8(2):73-6
pubmed: 26787653
Brain Dev. 1996 Mar-Apr;18(2):153-6
pubmed: 8733911
Mol Cell Neurosci. 2020 Oct;108:103540
pubmed: 32828964
Mol Genet Metab. 2007 Dec;92(4):371-4
pubmed: 17933575
J Inherit Metab Dis. 2008 Apr;31(2):258-66
pubmed: 18425435
Am J Hum Genet. 2001 Jun;68(6):1419-27
pubmed: 11326336
JIMD Rep. 2014;12:79-84
pubmed: 23900835
J Med Genet. 2005 Nov;42(11):829-36
pubmed: 15805149
J Biol Chem. 2007 Jun 1;282(22):16700-11
pubmed: 17420257
J Biol Chem. 2010 Jun 18;285(25):19316-23
pubmed: 20424173
J Clin Invest. 1991 Apr;87(4):1329-35
pubmed: 2010546
J Neurochem. 2011 Oct;119(1):1-5
pubmed: 21781115
Hum Genet. 1985;71(2):155-9
pubmed: 4043964
Clin Chim Acta. 1996 Mar 29;247(1-2):143-57
pubmed: 8920233
Biochem J. 1988 Feb 15;250(1):261-7
pubmed: 2451509
JCI Insight. 2018 Dec 20;3(24):
pubmed: 30568043
Eur J Pediatr. 1987 Mar;146(2):195-8
pubmed: 3569361
Monogr Hum Genet. 1978;10:16-22
pubmed: 723890
Chem Commun (Camb). 2016 Feb 7;52(11):2318-21
pubmed: 26727964
Twin Res Hum Genet. 2008 Jun;11(3):249-56
pubmed: 18498203
Genet Med. 2019 Feb;21(2):347-352
pubmed: 29875421
Glycoconj J. 2018 Aug;35(4):375-386
pubmed: 30088207
Nat Genet. 2016 Jul;48(7):777-84
pubmed: 27213289
Dev Med Child Neurol. 2004 Dec;46(12):832-7
pubmed: 15581157
Eur J Biochem. 1983 Jan 17;130(1):39-45
pubmed: 6297896
J Biol Chem. 2005 Jan 14;280(2):1408-16
pubmed: 15516337
Pediatr Nephrol. 2019 Jun;34(6):965-973
pubmed: 29789935
Glycobiology. 1992 Feb;2(1):25-40
pubmed: 1550987
Am J Med Genet A. 2003 Jul 1;120A(1):28-33
pubmed: 12794688
J Biol Chem. 1989 Sep 15;264(26):15247-54
pubmed: 2768261
Glycobiology. 1998 Jan;8(1):35-43
pubmed: 9451012
Am J Med Genet. 1999 Feb 19;82(5):385-91
pubmed: 10069709
J Biol Chem. 1991 Apr 25;266(12):7456-61
pubmed: 2019577
Proc Natl Acad Sci U S A. 1964 Aug;52:371-9
pubmed: 14206604
Nat Commun. 2017 Feb 06;8:14338
pubmed: 28165011
Biochimie. 2003 Mar-Apr;85(3-4):423-37
pubmed: 12770781
Adv Carbohydr Chem Biochem. 2018;75:1-213
pubmed: 30509400
Ultrasound Obstet Gynecol. 2001 Sep;18(3):272-4
pubmed: 11555460
Mol Genet Metab. 2004 Jun;82(2):137-43
pubmed: 15172001
J Pediatr. 1984 Feb;104(2):225-31
pubmed: 6420531
Prenat Diagn. 2006 Aug;26(8):655-8
pubmed: 16715535
FASEB J. 2013 Mar;27(3):1264-74
pubmed: 23221336
Front Pharmacol. 2019 Jul 01;10:724
pubmed: 31312139
Top Curr Chem. 2015;366:97-137
pubmed: 23842869
Biochem J. 1990 Jun 15;268(3):621-5
pubmed: 2363700
Exp Neurol. 2017 May;291:106-119
pubmed: 28189729
Mol Genet Metab. 2004 Jun;82(2):167-72
pubmed: 15172005
Biochim Biophys Acta. 2009 Apr;1793(4):636-49
pubmed: 19146888
Hum Gene Ther. 2019 Oct;30(10):1222-1235
pubmed: 31397176
Pediatr Neurol. 2017 Sep;74:87-91.e2
pubmed: 28662915
J Neurosci. 2009 Dec 9;29(49):15355-65
pubmed: 20007460
AJNR Am J Neuroradiol. 2003 Mar;24(3):398-400
pubmed: 12637289
Biosci Rep. 1999 Oct;19(5):373-83
pubmed: 10763805
FASEB J. 2017 Aug;31(8):3467-3483
pubmed: 28442549
J Biol Chem. 2005 Feb 11;280(6):4228-37
pubmed: 15557321
Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):814-8
pubmed: 8570640
Biochem J. 1984 Mar 1;218(2):625-8
pubmed: 6424662
CNS Neurol Disord Drug Targets. 2020;19(2):127-141
pubmed: 32053088
Ann Neurol. 2009 Jun;65(6):753-7
pubmed: 19557856
Annu Rev Biochem. 2003;72:395-447
pubmed: 12651740
J Med Chem. 2020 Aug 13;63(15):8231-8249
pubmed: 32608236
Nat Commun. 2014 Aug 14;5:4681
pubmed: 25119295
Hum Mol Genet. 2016 Jul 1;25(13):2752-2761
pubmed: 27270598
Genet Med. 2018 Apr;20(5):524-530
pubmed: 29048419
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):251-7
pubmed: 17123874
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11720-4
pubmed: 18695252
Am J Hum Genet. 1999 Jun;64(6):1563-9
pubmed: 10330343
Biochimie. 2001 Aug;83(8):727-37
pubmed: 11530204
Mol Genet Metab Rep. 2019 Sep 11;21:100513
pubmed: 31534909
Mol Genet Metab. 2002 Sep-Oct;77(1-2):99-107
pubmed: 12359136
Nat Genet. 1999 Dec;23(4):462-5
pubmed: 10581036
Semin Neurol. 2012 Feb;32(1):51-4
pubmed: 22422206
Orphanet J Rare Dis. 2018 Nov 6;13(1):196
pubmed: 30400963
J Extracell Vesicles. 2018 Mar 01;7(1):1440131
pubmed: 29535849
Trends Mol Med. 2008 Aug;14(8):351-60
pubmed: 18606570
Neuropediatrics. 1994 Oct;25(5):238-44
pubmed: 7885532
Brain. 2017 Dec 1;140(12):3191-3203
pubmed: 29140481
Eur J Biochem. 1982 Feb;122(2):305-11
pubmed: 7060578
Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35
pubmed: 21157483
Mol Genet Metab. 2004 Sep-Oct;83(1-2):6-15
pubmed: 15464415
J Inherit Metab Dis. 2018 May;41(3):515-523
pubmed: 29294191
Trends Cell Biol. 2020 Feb;30(2):133-143
pubmed: 31879153
Nat Commun. 2019 Dec 10;10(1):5630
pubmed: 31822666
Nat Genet. 2001 Sep;29(1):83-7
pubmed: 11528398
Mol Ther. 2013 Feb;21(2):433-44
pubmed: 23089735
Am J Hum Genet. 2000 Oct;67(4):832-40
pubmed: 10947946
Am J Med Genet A. 2017 Nov;173(11):2906-2911
pubmed: 28856833
J Ment Defic Res. 1985 Jun;29 ( Pt 2):179-86
pubmed: 4032465
EMBO J. 2004 Nov 24;23(23):4560-70
pubmed: 15510212
Biochim Biophys Acta. 2004 Jul 6;1673(1-2):56-65
pubmed: 15238249
Neurobiol Dis. 2004 Mar;15(2):251-61
pubmed: 15006695
Biochim Biophys Acta. 2016 Aug;1860(8):1640-54
pubmed: 26721333
Prenat Diagn. 2020 May;40(6):738-745
pubmed: 32134517
Front Mol Biosci. 2020 Sep 18;7:224
pubmed: 33062642
FASEB J. 2015 Jul;29(7):3040-53
pubmed: 25846372
Pediatr Neurol. 2002 Apr;26(4):267-73
pubmed: 11992753
Science. 1997 May 16;276(5315):1125-8
pubmed: 9173543
N Engl J Med. 2010 Nov 18;363(21):1991-2003
pubmed: 21083385
CNS Drugs. 2019 Apr;33(4):315-325
pubmed: 30877620
Biol Cell. 2008 Sep;100(9):551-9
pubmed: 18399798
Expert Opin Orphan Drugs. 2015;3(5):491-504
pubmed: 26949572
Mol Genet Metab Rep. 2019 Sep 18;21:100514
pubmed: 31641587
J Biol Chem. 2012 Mar 30;287(14):11489-97
pubmed: 22334707
Bone. 2018 May;110:343-354
pubmed: 29501587
J Inherit Metab Dis. 2016 May;39(3):457-464
pubmed: 26909499
Am J Med Genet A. 2005 Oct 15;138A(3):262-7
pubmed: 16158439
Clin Chim Acta. 1975 Apr 16;60(2):143-5
pubmed: 1126036
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7585-90
pubmed: 10840047
J Inherit Metab Dis. 2011 Oct;34(5):1069-73
pubmed: 21617927
Curr Top Med Chem. 2014;14(3):330-9
pubmed: 24283970
Nat Commun. 2019 Jul 3;10(1):2943
pubmed: 31270333
Eur J Med Genet. 2014 Sep;57(9):527-31
pubmed: 24993898
Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13434-9
pubmed: 22778404
Science. 1986 May 9;232(4751):759-62
pubmed: 3961501
Am J Med Genet A. 2003 Jul 1;120A(1):23-7
pubmed: 12794687

Auteurs

Marjan Huizing (M)

Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, United States. Electronic address: mhuizing@mail.nih.gov.

Mary E Hackbarth (ME)

Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, United States.

David R Adams (DR)

Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, United States.

Melissa Wasserstein (M)

Departments of Pediatrics and Genetics, The Children's Hospital at Montefiore, Bronx, NY, 10467, United States; Dominick P. Purpura Department of Neuroscience, Rose F. Kennedy Intellectual and Developmental Disabilities Research Center, Albert Einstein College of Medicine, Bronx, NY, 10461, United States.

Marc C Patterson (MC)

Department of Neurology, Mayo Clinic, Rochester, MN, 55905, United States.

Steven U Walkley (SU)

Dominick P. Purpura Department of Neuroscience, Rose F. Kennedy Intellectual and Developmental Disabilities Research Center, Albert Einstein College of Medicine, Bronx, NY, 10461, United States.

William A Gahl (WA)

Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH